Decreased Cytokine Activity [PE] - N0000008571

Pharmacologic Class Information

Pharmacologic Code N0000008571
Pharmacologic Name Decreased Cytokine Activity
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Decreased Cytokine Activity

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Decreased Cytokine Activity [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0003-2187Orencia Non-Proprietary Name: AbataceptInjection, Powder, Lyophilized, For SolutionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2188Orencia Non-Proprietary Name: AbataceptInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2814Orencia Non-Proprietary Name: AbataceptInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2818Orencia Non-Proprietary Name: AbataceptInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE